OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Computational systems biology approaches for Parkinson’s disease
Enrico Glaab
Cell and Tissue Research (2017) Vol. 373, Iss. 1, pp. 91-109
Open Access | Times Cited: 24
Enrico Glaab
Cell and Tissue Research (2017) Vol. 373, Iss. 1, pp. 91-109
Open Access | Times Cited: 24
Showing 24 citing articles:
Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions
Sezen Vatansever, Avner Schlessinger, Daniel Wacker, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1427-1473
Open Access | Times Cited: 261
Sezen Vatansever, Avner Schlessinger, Daniel Wacker, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1427-1473
Open Access | Times Cited: 261
Parkinson’s Disease: A Review from Pathophysiology to Treatment
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169
Prioritization of genes for translation: a computational approach
Simone C. da Silva Rosa, Amir Barzegar Behrooz, Sofia Guedes, et al.
Expert Review of Proteomics (2024) Vol. 21, Iss. 4, pp. 125-147
Closed Access | Times Cited: 5
Simone C. da Silva Rosa, Amir Barzegar Behrooz, Sofia Guedes, et al.
Expert Review of Proteomics (2024) Vol. 21, Iss. 4, pp. 125-147
Closed Access | Times Cited: 5
Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variation
Jochen Ohnmacht, Patrick May, Lasse Sinkkonen, et al.
Journal of Neural Transmission (2020) Vol. 127, Iss. 5, pp. 729-748
Open Access | Times Cited: 34
Jochen Ohnmacht, Patrick May, Lasse Sinkkonen, et al.
Journal of Neural Transmission (2020) Vol. 127, Iss. 5, pp. 729-748
Open Access | Times Cited: 34
PADG‐Pred: Exploring Ensemble Approaches for Identifying Parkinson's Disease Associated Biomarkers Using Genomic Sequences Analysis
Ayesha Karim, Tamim Alkhalifah, Fahad Alturise, et al.
IET Systems Biology (2025) Vol. 19, Iss. 1
Open Access
Ayesha Karim, Tamim Alkhalifah, Fahad Alturise, et al.
IET Systems Biology (2025) Vol. 19, Iss. 1
Open Access
Computational Attitude to Drug Discovery in Parkinson's Disease
Chitra Vellapandian, S. Ankul Singh, Swathi Suresh, et al.
(2025), pp. 271-311
Closed Access
Chitra Vellapandian, S. Ankul Singh, Swathi Suresh, et al.
(2025), pp. 271-311
Closed Access
Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease
Bhumika Kumar, Mukesh Pandey, Faheem Hyder Pottoo, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 37, pp. 4721-4737
Closed Access | Times Cited: 27
Bhumika Kumar, Mukesh Pandey, Faheem Hyder Pottoo, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 37, pp. 4721-4737
Closed Access | Times Cited: 27
Combining Automated Organoid Workflows with Artificial Intelligence‐Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High‐Throughput Screens for Parkinson's Disease and Beyond
Henrik Renner, Hans R. Schöler, Jan M. Bruder
Movement Disorders (2021) Vol. 36, Iss. 12, pp. 2745-2762
Open Access | Times Cited: 19
Henrik Renner, Hans R. Schöler, Jan M. Bruder
Movement Disorders (2021) Vol. 36, Iss. 12, pp. 2745-2762
Open Access | Times Cited: 19
Data Processing Method for AI‐Driven Predictive Models for CNS Drug Discovery
Ajantha Devi Vairamani, Sudipta Adhikary, Kaushik Banerjee
(2024), pp. 223-249
Closed Access | Times Cited: 2
Ajantha Devi Vairamani, Sudipta Adhikary, Kaushik Banerjee
(2024), pp. 223-249
Closed Access | Times Cited: 2
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Rong Xu, QuanQiu Wang
BMC Genomics (2016) Vol. 17, Iss. S7
Open Access | Times Cited: 22
Rong Xu, QuanQiu Wang
BMC Genomics (2016) Vol. 17, Iss. S7
Open Access | Times Cited: 22
Identification of biomarkers associated with Parkinson’s disease by gene expression profiling studies and bioinformatics analysis
Marios G. Krokidis
AIMS neuroscience (2019) Vol. 6, Iss. 4, pp. 333-345
Open Access | Times Cited: 22
Marios G. Krokidis
AIMS neuroscience (2019) Vol. 6, Iss. 4, pp. 333-345
Open Access | Times Cited: 22
The impact of sex differences on genomic research
Sabine Oertelt‐Prigione, Edwin C.M. Mariman
The International Journal of Biochemistry & Cell Biology (2020) Vol. 124, pp. 105774-105774
Open Access | Times Cited: 13
Sabine Oertelt‐Prigione, Edwin C.M. Mariman
The International Journal of Biochemistry & Cell Biology (2020) Vol. 124, pp. 105774-105774
Open Access | Times Cited: 13
Systems Biology to Address Unmet Medical Needs in Neurological Disorders
Masha G. Savelieff, Mohamed Noureldein, Eva L. Feldman
Methods in molecular biology (2022), pp. 247-276
Open Access | Times Cited: 8
Masha G. Savelieff, Mohamed Noureldein, Eva L. Feldman
Methods in molecular biology (2022), pp. 247-276
Open Access | Times Cited: 8
Neurodegenerative disorders: From clinicopathology convergence to systems biology divergence
Mauro Fasano, Tiziana Alberio
Handbook of clinical neurology (2023), pp. 73-86
Closed Access | Times Cited: 4
Mauro Fasano, Tiziana Alberio
Handbook of clinical neurology (2023), pp. 73-86
Closed Access | Times Cited: 4
Special issue “Parkinson’s disease”
Heiko Braak, Kelly Del Tredici-Braak, Thomas Gasser
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 1-7
Open Access | Times Cited: 12
Heiko Braak, Kelly Del Tredici-Braak, Thomas Gasser
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 1-7
Open Access | Times Cited: 12
Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson’s disease
Sunita Chawla, Dnyaneshwar Kalyane, Vishakha Tambe, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 2, pp. 392-405
Closed Access | Times Cited: 9
Sunita Chawla, Dnyaneshwar Kalyane, Vishakha Tambe, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 2, pp. 392-405
Closed Access | Times Cited: 9
Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression
Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos
Mathematical Biosciences & Engineering (2021) Vol. 18, Iss. 2, pp. 1813-1832
Open Access | Times Cited: 8
Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos
Mathematical Biosciences & Engineering (2021) Vol. 18, Iss. 2, pp. 1813-1832
Open Access | Times Cited: 8
Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus
Samuel Chima Ugbaja, Sphamandla E. Mtambo, Aganze Gloire-Aimé Mushebenge, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4376-4376
Open Access | Times Cited: 5
Samuel Chima Ugbaja, Sphamandla E. Mtambo, Aganze Gloire-Aimé Mushebenge, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4376-4376
Open Access | Times Cited: 5
Rational Design of Drugs for Neurodegenerative Disorders
Priyanka Kamaria
(2024), pp. 363-387
Closed Access
Priyanka Kamaria
(2024), pp. 363-387
Closed Access
Machine Learning Applications in the Study of Parkinson’s Disease: A Systematic Review
Jordi Martorell‐Marugán, Marco Chierici, Sara Bandrés‐Ciga, et al.
Current Bioinformatics (2023) Vol. 18, Iss. 7, pp. 576-586
Open Access | Times Cited: 1
Jordi Martorell‐Marugán, Marco Chierici, Sara Bandrés‐Ciga, et al.
Current Bioinformatics (2023) Vol. 18, Iss. 7, pp. 576-586
Open Access | Times Cited: 1
Gene Expression Profiling and Bioinformatics Analysis in Neurodegenerative Diseases
Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos
Springer eBooks (2023), pp. 967-1002
Closed Access | Times Cited: 1
Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos
Springer eBooks (2023), pp. 967-1002
Closed Access | Times Cited: 1
Novel computational deep learning strategy for neuroprotection identification reveals unique set of nicotine analogs as potential therapeutic compounds against Parkinson’s disease
Felipe Rojas-Rodríguez, Carlos Morantes, Andrés Pinzón, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Felipe Rojas-Rodríguez, Carlos Morantes, Andrés Pinzón, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Gene Expression Profiling and Bioinformatics Analysis in Neurodegenerative Diseases
Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos
Springer eBooks (2021), pp. 1-36
Closed Access | Times Cited: 1
Marios G. Krokidis, Themis P. Exarchos, Panagiotis Vlamos
Springer eBooks (2021), pp. 1-36
Closed Access | Times Cited: 1
Mass spectrometry–based approaches for the identification of molecular mechanism of action of ayurvedic medicines in Parkinson disease
Aparna Hegde, Shubham Sukerndeo Upadhyay, Thottethodi Subrahmanya Keshava Prasad, et al.
Elsevier eBooks (2023), pp. 425-459
Closed Access
Aparna Hegde, Shubham Sukerndeo Upadhyay, Thottethodi Subrahmanya Keshava Prasad, et al.
Elsevier eBooks (2023), pp. 425-459
Closed Access
Systems Medicine in Parkinson׳s Disease: Joining Efforts to Change History
Helena Xicoy, Miquel Vila, Ariadna Laguna
Elsevier eBooks (2020), pp. 1-14
Closed Access
Helena Xicoy, Miquel Vila, Ariadna Laguna
Elsevier eBooks (2020), pp. 1-14
Closed Access
